Key Financial Data Of Reporting Company

Astellas Pharma Inc. - Filing #7595393

Concept As at
2022-06-30
As at
2022-03-31
As at
2021-06-30
Key financial data of reporting company
Business results of reporting company
Cash and cash equivalents
313,013,000,000 JPY
315,986,000,000 JPY
301,920,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.